Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...

We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other ...

A boil water notice has been issued for the following areas of the Lilly Grove SUD Water System: FM 1638 (4700-4200 block FM ...

The stock's fall snapped a four-day winning streak.

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

We recently compiled a list of the 13 Best Dividend Growth Stocks With 10%+ Yearly Increases. In this article, we are going ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as ...

Thirty journalists have been awarded the Lilly Media Fellowship for their reports on Bangladesh's emerging cosmetics, skincare, and personal care industries.

Eli Lilly strengthens its pipeline with AdvanCell for targeted alpha therapies and partners with OliX to advance OLX75016 for MASH and cardiometabolic diseases.

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be short-lived deal ...

According to Bank of America, several companies are prime candidates for a stock split in the near future, which could lead to shares doubling the average market return, if historical trends are any ...

Eli Lilly & Co. is tapping the US investment-grade bond market on Monday to help finance its roughly $2.5 billion purchase of ...